{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:55:55Z","timestamp":1791442555908,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.breast.2026.104936","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:08:05Z","timestamp":1790060885000},"page":"104936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0698-777X","authenticated-orcid":false,"given":"Galip Can","family":"Uyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-730X","authenticated-orcid":false,"given":"Kadriye","family":"Ba\u015fkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0923-5148","authenticated-orcid":false,"given":"Ahmet","family":"Oru\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-5819","authenticated-orcid":false,"given":"Nargiz","family":"Majidova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0212-1191","authenticated-orcid":false,"given":"Orhun","family":"Akdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-702X","authenticated-orcid":false,"given":"Enes","family":"Ye\u015filba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-1605","authenticated-orcid":false,"given":"Kadriye","family":"Bir Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-5931","authenticated-orcid":false,"given":"Melek","family":"Karakurt Ery\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-2741","authenticated-orcid":false,"given":"Osman","family":"S\u00fctc\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2756-8646","authenticated-orcid":false,"given":"\u00d6m\u00fcr Berna","family":"\u00c7akmak \u00d6ks\u00fczo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-2362","authenticated-orcid":false,"given":"Mustafa","family":"Alt\u0131nba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.breast.2026.104936_bib1","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9938","key":"10.1016\/j.breast.2026.104936_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.breast.2026.104936_bib3","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","article-title":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer","volume":"6","author":"Roxburgh","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.breast.2026.104936_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr J"},{"issue":"6","key":"10.1016\/j.breast.2026.104936_bib6","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1016\/j.clbc.2020.05.008","article-title":"Can the neutrophil to lymphocyte ratio predict complete pathologic response to neoadjuvant breast cancer treatment? A systematic review and meta-analysis","volume":"20","author":"Cullinane","year":"2020","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"10.1016\/j.breast.2026.104936_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207224","article-title":"Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer","volume":"13","author":"Cuello-L\u00f3pez","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12885-025-13919-1","article-title":"NCR as a biomarker for nutritional status and inflammation in predicting outcomes in patients with cancer cachexia: a prospective, multicenter study","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib9","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1007\/s12672-025-03523-x","article-title":"Clinical value of the novel inflammatory-nutritional marker PALR in predicting early postoperative recurrence of colorectal cancer","volume":"16","author":"Xu","year":"2025","journal-title":"Discov Oncol"},{"issue":"7","key":"10.1016\/j.breast.2026.104936_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133830","article-title":"Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer","volume":"10","author":"Shao","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.25125","article-title":"High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy","volume":"118","author":"Fujimoto","year":"2018","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2026.104936_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9943","key":"10.1016\/j.breast.2026.104936_bib13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12944-024-02241-7","article-title":"Association between remnant cholesterol and the risk of 4 site-specific cancers: evidence from a cross-sectional and Mendelian randomization study","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12937-024-00951-3","article-title":"Remnant cholesterol is an effective biomarker for predicting survival in patients with breast cancer","volume":"23","author":"Shi","year":"2024","journal-title":"Nutr J"},{"issue":"11","key":"10.1016\/j.breast.2026.104936_bib16","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.numecd.2020.07.002","article-title":"Remnant cholesterol as a risk factor for cardiovascular, cancer or other causes mortality: a competing risks analysis","volume":"30","author":"Bonfiglio","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.breast.2026.104936_bib17","article-title":"Miller-payne grading and 70-Gene signature are associated with prognosis of hormone receptor-positive, human epidermal growth factor receptor 2-Negative early-stage breast cancer after neoadjuvant chemotherapy","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.breast.2026.104936_bib18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.116.308834","article-title":"Remnant cholesterol elicits arterial wall inflammation and a multilevel cellular immune response in humans","volume":"37","author":"Bernelot Moens","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12944-025-02580-z","article-title":"Remnant cholesterol inflammatory index and its association with all-cause and cause-specific mortality in middle-aged and elderly populations: evidence from US and Chinese national population surveys","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.breast.2026.104936_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2013.00119","article-title":"The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics","volume":"4","author":"Cruz","year":"2013","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.breast.2026.104936_bib21","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5667","article-title":"Cholesterol metabolism and cancer: molecular mechanisms, immune regulation and an epidemiological perspective","volume":"56","author":"He","year":"2025","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.breast.2026.104936_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae132","article-title":"Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis","volume":"111","author":"Dowling","year":"2024","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.breast.2026.104936_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-074874","article-title":"Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis","volume":"13","author":"Qi","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.breast.2026.104936_bib24","article-title":"Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.breast.2026.104936_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1323226","article-title":"A real-world clinicopathological model for predicting pathological complete response to neoadjuvant chemotherapy in breast cancer","volume":"14","author":"Fang","year":"2024","journal-title":"Front Oncol"},{"issue":"15","key":"10.1016\/j.breast.2026.104936_bib26","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.7150\/jca.97190","article-title":"Development and validation of an interpretable machine learning prediction model for total pathological complete response after neoadjuvant chemotherapy in locally advanced breast cancer: multicenter retrospective analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1186\/s12885-025-14335-1","article-title":"Clinical prediction of pathological complete response in breast cancer: a machine learning study","volume":"25","author":"He","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2026.104936_bib28","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S598948","article-title":"Inflammatory and nutritional biomarkers predict response to neoadjuvant dual Anti-HER2 therapy in HER2-Positive breast cancer: a retrospective cohort study","volume":"18","author":"\u015eahinli","year":"2026","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"issue":"16","key":"10.1016\/j.breast.2026.104936_bib31","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.22.02363","volume":"41","author":"Squifflet","year":"2023","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.breast.2026.104936_bib32","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2026.104936_bib33","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/j.clbc.2025.03.008","article-title":"A review of current literature and real-world outcomes with neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer","volume":"25","author":"Guzik","year":"2025","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104936_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/107327480701400103","article-title":"Interaction between comorbidity and cancer","volume":"14","author":"Extermann","year":"2007","journal-title":"Cancer Control"},{"issue":"3","key":"10.1016\/j.breast.2026.104936_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1373\/clinchem.2005.059832","article-title":"Serum tumor markers in breast cancer: are they of clinical value?","volume":"52","author":"Duffy","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.breast.2026.104936_bib36","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-16366-6_11","article-title":"Comorbidities and their management: potential impact on breast cancer outcomes","volume":"862","author":"Hong","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.breast.2026.104936_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4103\/ijc.ijc_1120_21","article-title":"Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: real-world data from a developing country","volume":"60","author":"Sharma","year":"2023","journal-title":"Indian J Cancer"},{"issue":"5","key":"10.1016\/j.breast.2026.104936_bib38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s12282-020-01096-x","article-title":"The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients","volume":"27","author":"Dan","year":"2020","journal-title":"Breast Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626002468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:48:05Z","timestamp":1791442085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626002468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S0960977626002468"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104936","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remnant cholesterol inflammatory index for predicting pathological complete response to neoadjuvant therapy in breast cancer: A multicenter external validation study","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104936"}}